A carregar...
Gliflozine – in Zukunft Kardioprotektiva?
Gliflozine (inhibitors of sodium-dependent glucose cotransporters, SGLT) are medications which were originally used in the treatment of diabetes mellitus and are assigned to the group of antidiabetics. Since November 2020 the SGLT2 inhibitor dapagliflozin has been approved for the treatment of heart...
Na minha lista:
| Publicado no: | Internist (Berl) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Medizin
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8260408/ https://ncbi.nlm.nih.gov/pubmed/34164700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00108-021-01083-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|